Carol Cardarelli

4.8k total citations · 1 hit paper
32 papers, 4.2k citations indexed

About

Carol Cardarelli is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Carol Cardarelli has authored 32 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Molecular Biology and 8 papers in Infectious Diseases. Recurrent topics in Carol Cardarelli's work include Drug Transport and Resistance Mechanisms (22 papers), HIV/AIDS drug development and treatment (8 papers) and Cancer therapeutics and mechanisms (6 papers). Carol Cardarelli is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), HIV/AIDS drug development and treatment (8 papers) and Cancer therapeutics and mechanisms (6 papers). Carol Cardarelli collaborates with scholars based in United States, Israel and France. Carol Cardarelli's co-authors include Michael M. Gottesman, Ira Pastan, Kazumitsu Ueda, Suresh V. Ambudkar, Marilyn M. Cornwell, I Pastan, Mark C. Willingham, Isabelle H. Lelong, Wilfred D. Stein and M M Gottesman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

Carol Cardarelli

31 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

1987 919 citations Kazumitsu Ueda, Carol Cardarelli et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Carol Cardarelli

Since Specialization

Citations

This map shows the geographic impact of Carol Cardarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Cardarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Cardarelli more than expected).

Fields of papers citing papers by Carol Cardarelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Cardarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Cardarelli. The network helps show where Carol Cardarelli may publish in the future.

Co-authorship network of co-authors of Carol Cardarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Cardarelli. A scholar is included among the top collaborators of Carol Cardarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Cardarelli. Carol Cardarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influence of Melanosome Dynamics on Melanoma Drug Sensitivity 2009 ·JNCI Journal of the National Cancer Institute ·Kevin G. Chen, Richard D. Leapman, Guofeng Zhang, Barry Lai, Julio C. Valencia, Carol Cardarelli, Wilfred D. Vieira, Vincent J. Hearing, Michael M. Gottesman	73
2	Differential phosphorylation patterns of P-glycoprotein reconstituted into a proteoliposome system: insight into additional unconventional phosphorylation sites. 2006 ·PubMed ·Isabelle Lelong-Rebel, Carol Cardarelli	16
3	Selective Toxicity of NSC73306 in MDR1-Positive Cells as a New Strategy to Circumvent Multidrug Resistance in Cancer 2006 ·Cancer Research ·Joseph A. Ludwig, Gergely Szakács, Scott E. Martin, Benjamin F. Chu, Carol Cardarelli, Zuben E. Sauna, Natasha J. Caplen, Henry M. Fales, Suresh V. Ambudkar, John N. Weinstein, Michael M. Gottesman	149
4	Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistance 2004 ·Molecular Pharmacology ·(unknown), Gergely Szakács, Charles J. Tucker, Angela Arciello, Carol Cardarelli, Jennifer Collins, Sherry F. Grissom, Barry R. Zeebèrg, William C. Reinhold, John N. Weinstein, Yves Pommier, Richard S. Paules, Michael M. Gottesman	69
5	Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells 2003 ·Experimental Cell Research ·Xing‐Jie Liang, Jun‐Jie Yin, (unknown), Paul Wang, Barbara J. Taylor, Carol Cardarelli, Michael P. Kozar, (unknown), Adorján Aszalós, Michael M. Gottesman	27
6	P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. 2003 ·PubMed ·(unknown), (unknown), Xing‐Jie Liang, Carol Cardarelli, Barbara J. Taylor, Jun‐Jie Yin, Adorján Aszalós, Michael M. Gottesman	56
7	Modulation by the ATP/GTP ratio of the phosphorylation level of P-glycoprotein and of various plasma membrane proteins of KB-V1 multidrug resistant cells. 2003 ·PubMed ·Isabelle Lelong-Rebel, G. Rebel, Carol Cardarelli, I Pastan, Michael M. Gottesman	8
8	Low and High Concentrations of the Topo II Inhibitor Daunorubicin in NIH3T3 Cells: Reversible G2/M Versus Irreversible G1 and S Arrest 2003 ·Cell Cycle ·Wilfred D. Stein, Robert W. Robey, Carol Cardarelli, Michael M. Gottesman, Susan E. Bates	6
9	[17] Selection and maintenance of multidrug-resistant cells 1998 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Michael M. Gottesman, Carol Cardarelli, Sarah Goldenberg, Thomas Licht, Ira Pastan	15
10	[36] Purification and reconstitution of human P-glycoprotein 1998 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Suresh V. Ambudkar, Isabelle H. Lelong, Ping Zhang, Carol Cardarelli	36
11	Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein 1997 ·Journal of Biological Chemistry ·Suresh V. Ambudkar, Carol Cardarelli, (unknown), Wilfred D. Stein	165
12	Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity. 1996 ·PubMed ·I Aksentijevich, Carol Cardarelli, Ira Pastan, M M Gottesman	8
13	Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells 1996 ·Journal of Biological Chemistry ·Ursula A. Germann, Timothy C. Chambers, Suresh V. Ambudkar, Thomas Licht, Carol Cardarelli, Ira Pastan, Michael M. Gottesman	149
14	GTP-Stimulated Phosphorylation of P-Glycoprotein in Transporting Vesicles from KB-V1 Multidrug Resistant Cells 1994 ·Biochemistry ·Isabelle H. Lelong, Carol Cardarelli, Michael M. Gottesman, Ira Pastan	20
15	Gene Transfer of Drug Resistance Genes Implications for Cancer Therapy 1994 ·Annals of the New York Academy of Sciences ·Michael M. Gottesman, Ursula A. Germann, I Aksentijevich, Yoshikazu Sugimoto, Carol Cardarelli, Ira Pastan	27
16	Exploiting Multidrug Resistance to Treat Cancer 1994 ·Cold Spring Harbor Symposia on Quantitative Biology ·Michael M. Gottesman, Suresh V. Ambudkar, B. Ni, Josep M. Aran, Y. Sugimoto, Carol Cardarelli, Ira Pastan	22
17	Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. 1992 ·Proceedings of the National Academy of Sciences ·Suresh V. Ambudkar, Isabelle H. Lelong, (unknown), Carol Cardarelli, M M Gottesman, I Pastan	343
18	A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells. 1987 ·Proceedings of the National Academy of Sciences ·D J FitzGerald, M C Willingham, Carol Cardarelli, Hiroyuki Hamada, T Tsuruo, M M Gottesman, I Pastan	120
19	Molecular biology of drug resistance 1987 ·Breast Cancer Research and Treatment ·Antonio Tito Fojo, Marilyn M. Cornwell, Carol Cardarelli, Douglas P. Clark, Nancy Richert, Ding‐Wu Shen, Kazumitsu Ueda, Mark C. Willingham, Michael M. Gottesman, Ira Pastan	23
20	Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. 1986 ·PubMed ·Mark C. Willingham, Marilyn M. Cornwell, Carol Cardarelli, Michael M. Gottesman, Ira Pastan	286

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact